TD Asset Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-131,680
| Closed | -$1.89M | – | 1274 |
|
|
2024
Q4 | $1.89M | Sell |
131,680
-126,478
| -49% | -$1.82M | ﹤0.01% | 1026 |
|
|
2024
Q3 | $5.85M | Sell |
258,158
-26,406
| -9% | -$599K | 0.01% | 763 |
|
|
2024
Q2 | $5.53M | Sell |
284,564
-95,000
| -25% | -$1.85M | 0.01% | 741 |
|
|
2024
Q1 | $14.2M | Buy |
379,564
+104,400
| +38% | +$3.92M | 0.01% | 560 |
|
|
2023
Q4 | $15.4M | Buy |
275,164
+36,800
| +15% | +$2.06M | 0.02% | 526 |
|
|
2023
Q3 | $9.83M | Buy |
238,364
+100,382
| +73% | +$4.14M | 0.01% | 590 |
|
|
2023
Q2 | $7.7M | Sell |
137,982
-6,348
| -4% | -$354K | 0.01% | 657 |
|
|
2023
Q1 | $8.05M | Buy |
144,330
+34,982
| +32% | +$1.95M | 0.01% | 638 |
|
|
2022
Q4 | $3.98M | Sell |
109,348
-20,900
| -16% | -$762K | ﹤0.01% | 797 |
|
|
2022
Q3 | $3.9M | Buy |
130,248
+72,100
| +124% | +$2.16M | ﹤0.01% | 811 |
|
|
2022
Q2 | $2.63M | Sell |
58,148
-4,385
| -7% | -$198K | ﹤0.01% | 928 |
|
|
2022
Q1 | $4.76M | Buy |
62,533
+2,538
| +4% | +$193K | ﹤0.01% | 836 |
|
|
2021
Q4 | $8.94M | Buy |
59,995
+4,806
| +9% | +$716K | 0.01% | 708 |
|
|
2021
Q3 | $8.03M | Buy |
55,189
+30
| +0.1% | +$4.37K | 0.01% | 699 |
|
|
2021
Q2 | $10.1M | Buy |
55,159
+15,306
| +38% | +$2.8M | 0.01% | 643 |
|
|
2021
Q1 | $7.21M | Buy |
39,853
+2,624
| +7% | +$475K | 0.01% | 726 |
|
|
2020
Q4 | $5.27M | Buy |
37,229
+12,990
| +54% | +$1.84M | 0.01% | 777 |
|
|
2020
Q3 | $3.02M | Buy |
24,239
+4,795
| +25% | +$598K | ﹤0.01% | 827 |
|
|
2020
Q2 | $1.74M | Buy |
19,444
+4,000
| +26% | +$357K | ﹤0.01% | 912 |
|
|
2020
Q1 | $962K | Buy |
15,444
+5,800
| +60% | +$361K | ﹤0.01% | 1007 |
|
|
2019
Q4 | $735K | Sell |
9,644
-2,763
| -22% | -$211K | ﹤0.01% | 1168 |
|
|
2019
Q3 | $625K | Buy |
+12,407
| New | +$625K | ﹤0.01% | 1142 |
|